Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

Nicholas G. Zaorsky; Daniel E. Spratt; Amar U. Kishan; Stephen H. Culp; Timothy N. Showalter

doi:10.3389/fonc.2020.01616

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

Nicholas G. Zaorsky, Daniel E. Spratt, Amar U. Kishan, Stephen H. Culp, Timothy N. Showalter

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Article number	1616
Journal	Frontiers in Oncology
Volume	10
DOIs	https://doi.org/10.3389/fonc.2020.01616
State	Published - Aug 27 2020

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

Access to Document

10.3389/fonc.2020.01616

Cite this

@article{1505c18e988f450a91f80148a537360b,

title = "Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options",

author = "Zaorsky, {Nicholas G.} and Spratt, {Daniel E.} and Kishan, {Amar U.} and Culp, {Stephen H.} and Showalter, {Timothy N.}",

note = "Funding Information: Funding. NZ was supported by startup funding from Penn State Cancer Institute and Penn State College of Medicine. NZ was supported by the National Institutes of Health Grant LRP 1 L30 CA231572-01. NZ was supported by the American Cancer Society – Tri State CEOs Against Cancer Clinician Scientist Development Grant, CSDG-20-013-01-CCE. NZ received remuneration from Springer Nature for his textbook and Absolute Clinical Radiation Oncology Review.",

year = "2020",

month = aug,

day = "27",

doi = "10.3389/fonc.2020.01616",

language = "English (US)",

volume = "10",

journal = "Frontiers in Oncology",

issn = "2234-943X",

publisher = "Frontiers Media S. A.",

}

TY - JOUR

T1 - Editorial

T2 - Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

AU - Zaorsky, Nicholas G.

AU - Spratt, Daniel E.

AU - Kishan, Amar U.

AU - Culp, Stephen H.

AU - Showalter, Timothy N.

N1 - Funding Information: Funding. NZ was supported by startup funding from Penn State Cancer Institute and Penn State College of Medicine. NZ was supported by the National Institutes of Health Grant LRP 1 L30 CA231572-01. NZ was supported by the American Cancer Society – Tri State CEOs Against Cancer Clinician Scientist Development Grant, CSDG-20-013-01-CCE. NZ received remuneration from Springer Nature for his textbook and Absolute Clinical Radiation Oncology Review.

PY - 2020/8/27

Y1 - 2020/8/27

UR - http://www.scopus.com/inward/record.url?scp=85091379741&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85091379741&partnerID=8YFLogxK

U2 - 10.3389/fonc.2020.01616

DO - 10.3389/fonc.2020.01616

M3 - Editorial

C2 - 32984028

AN - SCOPUS:85091379741

SN - 2234-943X

VL - 10

JO - Frontiers in Oncology

JF - Frontiers in Oncology

M1 - 1616

ER -

Editorial: Optimizing Local Therapy for High-Risk Prostate Cancer: Evidence and Emerging Options

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this